生物防禦市場規模、佔有率及成長分析（按產品、應用、最終用戶及地區分類）－2026-2033年產業預測

預計到 2024 年，全球生物防禦市場規模將達到 152.9 億美元，到 2025 年將達到 162.4 億美元，到 2033 年將達到 262.7 億美元，在預測期（2026-2033 年）內，複合年成長率為 6.2%。

由於政府主導力度加大、投資增加以及對生物防禦策略的高度重視，全球生物防禦市場正經歷顯著成長。人們對流感、茲卡和伊波拉出血熱等感染疾病的日益關注，進一步凸顯了採取強力的生物防禦措施的迫切性。基因工程和生物技術的進步使得改造致命病毒成為可能，因此全面的防禦措施至關重要。隨著生物威脅在全球日益普遍，生物防禦對國家安全仍然至關重要。過去涉及炭疽菌等病原體的生物恐怖攻擊事件凸顯了這些威脅的經濟影響，促使各國政府制定了各種法規和條約。專注於感染疾病診斷和治療的機構正在進行的研究，進一步支持了有效應對潛在生物攻擊的措施的開發，從而強化了生物防禦準備的重要性。

全球生物防禦市場促進因素

全球生物防禦市場主要由聯邦和州政府為加強國家和公共衛生安全而進行的大量投資所驅動。這些財政投入對於疫苗、診斷和治療方法的研發至關重要，確保醫療衛生系統能夠充分應對生物威脅。此外，政府在緊急時應對計畫和培訓方面的支出，也為創新生物防禦解決方案的推進創造了有利環境。這項具有前瞻性的措施最終增強了抵禦潛在生物攻擊和流行病的能力，凸顯了有效生物防禦策略在保護公眾健康方面的關鍵作用。

限制全球生物防禦市場的因素

全球生物防禦市場面臨嚴峻挑戰，現有企業之間的激烈競爭是造成此局面的主要原因。這種競爭導致價格戰和利潤率下降，為新進入者設置了重重障礙。市場主導企業利用其雄厚的資源和與監管機構的密切關係，實施激進的定價策略以維持其市場地位。這些策略不僅擠壓了利潤空間，也扼殺了小型企業的成長潛力，最終阻礙了這個對公共衛生和安全至關重要的領域的創新和競爭。

全球生物防禦市場趨勢

在全球基因組學和生物技術進步的推動下，全球生物防禦市場正經歷著向個人化醫療的重大轉變。這一趨勢強調開發針對特定生物威脅和不同人群獨特基因特徵的客製化疫苗和治療方法。個人化醫療能夠更精準、更有效率地應對感染疾病，進而提升生物防禦策略的效用。隨著技術的進步，高效、針對特異性族群的疫苗的潛力日益增強，這進一步凸顯了開發能夠解決個人脆弱性和社區健康問題的適應性醫療解決方案的必要性。這有可能重塑全球生物防禦格局。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管環境
• 案例研究
• 技術分析

全球生物防禦市場規模（依產品分類）及複合年成長率（2026-2033 年）

• 疫苗
  • 炭疽菌
  • 天花
  • 肉毒桿菌中毒
  • 其他
• 威脅偵測設備
  • 採樣裝置
  • 探測器/執行器
  • 識別裝置
  • 檢測方法和試劑

全球生物防禦市場規模（依應用領域及複合年成長率分類）（2026-2033 年）

• 軍隊
• 私部門

全球生物防禦市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院和診所
• 門診治療中心
• 其他

全球生物防禦市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Emergent BioSolutions Inc.（United States）
• SIGA Technologies, Inc.（United States）
• Dynavax Technologies Corporation（United States）
• Altimmune Inc.（United States）
• XOMA Corporation（United States）
• Cleveland BioLabs Inc.（United States）
• Ichor Medical Systems, Inc.（United States）
• ANP Technologies, Inc.（United States）
• PositiveID Corporation（United States）
• Alexeter Technologies LLC（United States）
• BioFire Defense（bioMerieux SA）（United States）
• Elusys Therapeutics Inc.（United States）
• Battelle National Biodefense Institute, LLC（United States）
• Gryphon Scientific LLC（United States）
• BioRisk Reduction（United States）
• CBRNe Science and Consequence Management World Congress（United States）
• Mammoth Biosciences（United States）
• Alnylam Pharmaceuticals Inc.（United States）
• Bruker Detection（United States）
• New Horizon Diagnostic Corp.（United States）

結論與建議

Global Biodefense Market size was valued at USD 15.29 Billion in 2024 and is poised to grow from USD 16.24 Billion in 2025 to USD 26.27 Billion by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).

The global biodefense market is experiencing significant growth due to heightened government initiatives and increased investments, alongside a strong emphasis on biodefense strategies. Rising concerns over infectious diseases such as flu, Zika, and Ebola enhance the urgency for robust biodefense measures. Advances in genetic engineering and biotechnology enable the modification of lethal viruses, necessitating comprehensive defenses. With biological threats prevalent worldwide, biodefense remains crucial for national security. Historical instances of bioterrorism using agents like anthrax underscore the financial impact of such threats, prompting governments to establish various statutes and treaties. Ongoing research by institutions focused on diagnosing and treating infectious diseases further aids in developing effective responses to potential biological attacks, reinforcing the importance of biodefense preparedness.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biodefense market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biodefense Market Segments Analysis

Global Biodefense Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Vaccines and Biothreat Detection Devices. Based on Application, the market is segmented into Military and Civilian. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biodefense Market

The Global Biodefense market is significantly fueled by the substantial investments made by federal and state governments aimed at enhancing national and public health security. These financial commitments are essential for the development of vaccines, diagnostics, and treatments, ensuring that healthcare systems are adequately prepared to confront biological threats. Furthermore, government expenditures on emergency planning infrastructure and training create an environment conducive to the advancement of innovative biodefense solutions. This proactive approach ultimately fosters resilience against potential biological attacks or pandemics, highlighting the critical importance of effective biodefense strategies in safeguarding public health.

Restraints in the Global Biodefense Market

The Global Biodefense market faces significant challenges due to intense competition among established companies. This rivalry can result in price wars and reduced profit margins, creating barriers for new entrants attempting to penetrate the market. Dominant players benefit from abundant resources and well-established connections with regulatory authorities, allowing them to implement aggressive pricing strategies to maintain their market positions. Such tactics not only compress profit margins but also hinder the growth potential of smaller firms, ultimately stifling innovation and competition within this critical sector that is essential for public health and safety.

Market Trends of the Global Biodefense Market

The Global Biodefense market is experiencing a significant shift towards personalized medicine, driven by advancements in genomics and biotechnology. This trend emphasizes the development of customized vaccines and treatments tailored to address specific biological threats and the unique genetic profiles of various populations. Personalized medicine enhances the efficacy of biodefense strategies by enabling more precise and efficient responses to infectious diseases. As technologies evolve, the potential for highly effective, population-specific vaccines increases, reinforcing the need for adaptive health solutions that cater to individual vulnerabilities and regional health concerns, which is poised to redefine the landscape of biodefense initiatives globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Biodefense Market Size by Product & CAGR (2026-2033)

• Market Overview
• Vaccines
  • Anthrax
  • Smallpox
  • Botulism
  • Others
• Biothreat Detection Devices
  • Samplers
  • Detectors/Triggering Devices
  • Identifiers
  • Assays and Reagents

Global Biodefense Market Size by Application & CAGR (2026-2033)

• Market Overview
• Military
• Civilian

Global Biodefense Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Global Biodefense Market Size & CAGR (2026-2033)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Emergent BioSolutions Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIGA Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altimmune Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• XOMA Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cleveland BioLabs Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ichor Medical Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANP Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PositiveID Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alexeter Technologies LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioFire Defense (bioMerieux SA) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elusys Therapeutics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Battelle National Biodefense Institute, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gryphon Scientific LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioRisk Reduction (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CBRNe Science and Consequence Management World Congress (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alnylam Pharmaceuticals Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Detection (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New Horizon Diagnostic Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations